United States · Exchanges & live quotes · Nasdaq
Zymeworks Authorized To Buy Back Up To $200 Mln Of Shares
Detailed summary
(RTTNews) - Zymeworks Inc. (ZYME), a biotechnology company, said Monday that its Board has authorized a second share repurchase program of up to $200 million, which is expected to…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)


